FOS and cancer: Among the DEGs positively modulated in SCE17-exposed cells, we can highlight genes involved in cancer progression, such as FOS, JUN, and JUNB proto-oncogenes, Cyclin Dependent Kinase Inhibitor 1A (CDKN1A), and Tumor Protein 53 Inducible Nuclear Protein 1 (TP53INP1).